Regulatory News:
Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a biopharmaceutical ...
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
Regulatory News: Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a biopharmaceutical …